Sahni Sabrina, Lobo-Romero Angie, Smith Taryn
Division of General Internal Medicine, Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA.
Division of General Internal Medicine, Women's Health, Mayo Clinic Rochester, MN, USA.
touchREV Endocrinol. 2021 Nov;17(2):133-137. doi: 10.17925/EE.2021.17.2.133. Epub 2021 Oct 13.
Nearly 75% of all menopausal women experience bothersome vasomotor symptoms including hot flushes and night sweats. Yet vasomotor symptoms continue to be an undertreated and underdiagnosed symptom of menopause which can negatively affect a woman's overall quality of life. While hormone therapy has been widely utilized to ameliorate hot flushes, not all women are candidates for use, especially those with increased risk of cardiovascular disease, thromboembolic disease, and/or women at an increased risk of certain hormone-dependent cancers. The current literature provides strong evidence for non-hormonal therapies in women who experience vasomotor symptoms. This article reviews the evidence for the use of non-hormonal pharmacologic therapies for the treatment of menopausal symptoms including antidepressants, gabapentinoids, clonidine and anticholinergics. We also review data on emerging therapies including the latest evidence on neurokinin-1 and -3 antagonists. These therapies should be considered when hormonal options are contraindicated and/or not preferred by the patient. While there are many options available, clinicians should individualize therapy based on the patient's needs and goals while mitigating bothersome side effects.
近75%的绝经后女性会出现令人困扰的血管舒缩症状,包括潮热和盗汗。然而,血管舒缩症状仍然是绝经的一种治疗不足和诊断不足的症状,会对女性的整体生活质量产生负面影响。虽然激素疗法已被广泛用于改善潮热,但并非所有女性都适合使用,尤其是那些心血管疾病、血栓栓塞性疾病风险增加的女性,以及某些激素依赖性癌症风险增加的女性。目前的文献为有血管舒缩症状的女性采用非激素疗法提供了有力证据。本文综述了使用非激素药物疗法治疗绝经症状的证据,包括抗抑郁药、加巴喷丁类药物、可乐定和抗胆碱能药物。我们还综述了新兴疗法的数据,包括神经激肽-1和-3拮抗剂的最新证据。当激素治疗方案存在禁忌和/或患者不倾向于使用时,应考虑这些疗法。虽然有多种选择,但临床医生应根据患者的需求和目标个体化治疗,同时减轻令人困扰的副作用。